54
Views
216
CrossRef citations to date
0
Altmetric
Gene Expression

The Parafibromin Tumor Suppressor Protein Is Part of a Human Paf1 Complex

, , , , , , & show all
Pages 612-620 | Received 30 Jun 2004, Accepted 18 Oct 2004, Published online: 27 Mar 2023
 

Abstract

Parafibromin, the product of the HRPT2 (hyperparathyroidism-jaw tumor syndrome 2) tumor suppressor gene, is the human homologue of yeast Cdc73, part of the yeast RNA polymerase II/Paf1 complex known to be important for histone modification and connections to posttranscriptional events. By purifying cellular parafibromin and characterizing its associated proteins, we have identified a human counterpart to the yeast Paf1 complex including homologs of Leo1, Paf1, and Ctr9. Like the yeast complex, the parafibromin complex associates with the nonphosphorylated and Ser2 and Ser5 phosphorylated forms of the RNA polymerase II large subunit. Immunofluorescence experiments show that parafibromin is a nuclear protein. In addition, cotransfection data suggest that parafibromin can interact with a histone methyltransferase complex that methylates histone H3 on lysine 4. Some mutant forms of parafibromin lack association with hPaf1 complex members and with the histone methyltransferase complex, suggesting that disruption of these complexes may correlate with the oncogenic process.

ACKNOWLEDGMENTS

We thank E. McIntush at Bethyl Laboratories for antibody design, E. Kort and E. Hudson for immunofluorescence assay assistance, and J. W. Lee for the ASC-2 antibody. We are grateful to the Taplin Biological Institute for mass spectrometry analysis and Bethyl Laboratories for preparation of polyclonal antibodies. We also thank J. Jaehning and G. David for critical comments on the manuscript and helpful discussions.

This work was supported by a gift from Raymond and Beverly Sackler.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.